. "600"^^ . . . . . . . . . . . . . "A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04"@en . . . . . . . . . . . "A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04"@en . . . "clinical trial"@en . . . . . . . . . . "A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04"@en . "ensayu cl\u00EDnicu"@ast . . . . . "NCT03383146" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "\u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0435 \u0432\u0438\u043F\u0440\u043E\u0431\u0443\u0432\u0430\u043D\u043D\u044F"@uk . "2020-09-28T00:00:00Z"^^ . . . . . . . . . . "klinisch onderzoek"@nl . . . . . . . . . . . "18"^^ . . . . . . "A 52-week, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Relamorelin in Patients With Diabetic Gastroparesis"@en . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "2017-12-19T00:00:00Z"^^ . . .